Image
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (696)
Page
Progyny
Evernorth has expanded benefit offerings across family-planning, fertility, pregnancy and postpartum care for employers and health plans through our partnership with Progyny. Evernorth is committed to addressing disparities in this category of health benefits and has designed an end-to-end, inclusive benefit in family-planning care for plan members across both in-house capabilities and new partnership solutions.
Article
Innovation in health benefits management
May 06, 2025
Employers can take the lead by leveraging technology and data innovation to solve challenges and improve health outcomes.
Article
Unlocking value with smarter health care point solutions
Jul 08, 2025
Learn more about the power of the right point solutions and why it matters to employers.
Image
Article
Evernorth Specialty Services patient spotlight: Dave
May 28, 2025
Meet Dave, an Accredo patient living with common variable immune deficiency (CVID). With the support of Accredo's specialized team, Dave is better enabled to live life on his own terms.
Image
Article
Most Favored Nation policy cannot succeed without the pharmacy benefit
May 20, 2025
Considering President Trump’s recent executive order, we examine the Most Favored Nation prescription drug pricing policy to the pharmacy benefit and discuss how removing PBMs – “the middleman” – is oversimplified and shortsighted.
Image
Article
Guiding a customer through extreme grief
May 22, 2025
Read the inspiring story of how Mary Beth Hull helped a customer navigate the overwhelming grief of losing a close family member.
Newsroom
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
May 21, 2025
• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible
• New offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patients